English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/9267
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Synthesis of a Novel Ceramide Analogue and its Use in a High-Throughput Fluorogenic Assay for Ceramidases

AuthorsBedia, Carmen ; Casas, Josefina ; Garcia, Virginie; Levade, Thierry; Fabriàs, Gemma
KeywordsAcidic ceramidase
Amides
Enzymes
Fluorescence
Inhibitors
Issue Date16-Mar-2007
PublisherJohn Wiley & Sons
CitationChembiochem 8(6): 642-648 (2007)
AbstractSeveral investigations have shown that acid ceramidase inhibitors are potential antiproliferative and cytostatic drugs for cancer chemotherapy. The combinatorial chemistry approach for the discovery of acid ceramidase inhibitors requires the availability of a high-throughput enzyme assay. The synthesis of a novel fluorogenic ceramidase substrate, and its processing both in vitro and in cultured cells in a microtiter plate layout, are reported in this article. This coumarinic substrate was hydrolyzed in vitro (rat liver lysosomes) with Km and Vmax values of 113 μm and 3.6 pmol min-1 mg-1, respectively. Similarly, hydrolysis occurred in intact cultured cells that overexpressed acidic ceramidase. The assay was validated for the identification and characterization of acidic ceramidase inhibitors by using several α-ketoamide ceramide analogues, whose inhibitory activity had been previously described.
Description7 pages, 3 figures.-- PMID: 17361980 [PubMed].
Publisher version (URL)http://dx.doi.org/10.1002/cbic.200600533
URIhttp://hdl.handle.net/10261/9267
DOIhttp://dx.doi.org/10.1002/cbic.200600533
ISSN1439-7633
Appears in Collections:(IQAC) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.